HBIOX
Price
$20.75
Change
+$0.10 (+0.48%)
Updated
Nov 12 closing price
Net Assets
835.98M
VTIAX
Price
$40.68
Change
+$0.20 (+0.49%)
Updated
Nov 12 closing price
Net Assets
554.27B
Interact to see
Advertisement

HBIOX vs VTIAX

Header iconHBIOX vs VTIAX Comparison
Open Charts HBIOX vs VTIAXBanner chart's image
Hartford International Opp HLS IB
Price$20.75
Change+$0.10 (+0.48%)
VolumeN/A
Net Assets835.98M
Vanguard Total Intl Stock Index Admiral
Price$40.68
Change+$0.20 (+0.49%)
VolumeN/A
Net Assets554.27B
HBIOX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
HBIOX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIOX is a StrongBuy and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. HBIOX (836M). VTIAX pays higher dividends than HBIOX: VTIAX (2.70) vs HBIOX (1.31). HBIOX was incepted earlier than VTIAX: HBIOX (28 years) vs VTIAX (15 years). HBIOX (1.02) is less costly to investors than VTIAX (0.09). HBIOX is a more actively managed with annual turnover of: 43.00 vs. VTIAX (3.00). HBIOX has a lower initial minimum investment than VTIAX: HBIOX (0) vs VTIAX (3000). HBIOX (25.25) and VTIAX (25.12) have marching annual gain over last year. VTIAX return over 5 years is better than : 39.59 vs. HBIOX (19.17).
HBIOXVTIAXHBIOX / VTIAX
Total Expense Ratio1.020.091,133%
Annual Report Gross Expense Ratio1.020.091,133%
Fund Existence28 years15 years-
Gain YTD27.45328.91295%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets836M554B0%
Annual Yield % from dividends1.312.7049%
Returns for 1 year25.2525.12101%
Returns for 3 years57.0349.28116%
Returns for 5 years19.1739.5948%
Returns for 10 years65.3979.3582%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp